1Drop is a life science company based in Boston, MA and Neuchatel, Switzerland that develops and commercializes a laboratory-quality, portable medical diagnostic testing platform. Led by founder and CEO Dr. Luc Gervais, the company enables personalized healthcare through non-invasive diagnostic tests that provide actionable health information from a single drop of blood applied to a biochip. Its diagnostic solutions support multiplexed assays of proteins, nucleic acids and peptides for new therapy development, disease research and clinical diagnostic tests. The company’s device has been clinically validated in hospitals, clinical laboratories and with pharmaceutical companies. 1Drop collaborates with Massachusetts General Hospital, Harvard University, NASA and EPFL and is working with three pharmaceutical partners to create companion diagnostics for cardiology, autoimmune disease and glucose metabolism drug candidates. Following its Series A, 1Drop plans to expand research and development and to commercialize its medical diagnostics platform.

Total raised

$4M

Funding rounds

1

Latest round

Series A

Latest activity

Oct 2018